122 related articles for article (PubMed ID: 16842173)
1. Stimulating effects of H1-antagonists.
Theunissen EL; Vermeeren A; Vuurman EF; Ramaekers JG
Curr Pharm Des; 2006; 12(20):2501-9. PubMed ID: 16842173
[TBL] [Abstract][Full Text] [Related]
2. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
[TBL] [Abstract][Full Text] [Related]
3. Comparing the stimulant effects of the H1-antagonist fexofenadine with 2 psychostimulants, modafinil and methylphenidate.
Theunissen EL; Elvira Jde L; van den Bergh D; Ramaekers JG
J Clin Psychopharmacol; 2009 Oct; 29(5):439-43. PubMed ID: 19745643
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
[TBL] [Abstract][Full Text] [Related]
5. A combined neurophysiological and behavioural study into the stimulating effects of fexofenadine on performance.
Theunissen EL; Jonkman LM; Kuypers KP; Ramaekers JG
J Psychopharmacol; 2006 Jul; 20(4):496-505. PubMed ID: 16174671
[TBL] [Abstract][Full Text] [Related]
6. Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor.
Wu RL; Anthes JC; Kreutner W; Harris AG; West RE
Int Arch Allergy Immunol; 2004 Dec; 135(4):313-8. PubMed ID: 15564772
[TBL] [Abstract][Full Text] [Related]
7. Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain.
Tashiro M; Mochizuki H; Iwabuchi K; Sakurada Y; Itoh M; Watanabe T; Yanai K
Life Sci; 2002 Dec; 72(4-5):409-14. PubMed ID: 12467881
[TBL] [Abstract][Full Text] [Related]
8. Stimulating effects of the antihistamine fexofenadine: testing the dopamine transporter hypothesis.
Theunissen EL; van Kroonenburgh MJ; van Deursen JA; Blom-Coenjaerts C; Ramaekers JG
Psychopharmacology (Berl); 2006 Jul; 187(1):95-102. PubMed ID: 16767419
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacology of H1 antihistamines: clinical relevance.
Simons FE
Am J Med; 2002 Dec; 113 Suppl 9A():38S-46S. PubMed ID: 12517581
[TBL] [Abstract][Full Text] [Related]
10. Ciproxifan and chemically related compounds are highly potent and selective histamine H3-receptor antagonists.
Kathmann M; Schlicker E; Marr I; Werthwein S; Stark H; Schunack W
Naunyn Schmiedebergs Arch Pharmacol; 1998 Dec; 358(6):623-7. PubMed ID: 9879720
[TBL] [Abstract][Full Text] [Related]
11. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms.
Roumestan C; Henriquet C; Gougat C; Michel A; Bichon F; Portet K; Jaffuel D; Mathieu M
Clin Exp Allergy; 2008 Jun; 38(6):947-56. PubMed ID: 18498541
[TBL] [Abstract][Full Text] [Related]
12. Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
Antonijoan R; García-Gea C; Puntes M; Pérez J; Esbrí R; Serra C; Fortea J; Barbanoj MJ
Clin Ther; 2007 May; 29(5):814-822. PubMed ID: 17697901
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory activity of H1-receptor antagonists: review of recent experimental research.
Gelfand EW; Appajosyula S; Meeves S
Curr Med Res Opin; 2004 Jan; 20(1):73-81. PubMed ID: 14741075
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the histamine receptors in the guinea-pig lung: evidence for relaxant histamine H3 receptors in the trachea.
Cardell LO; Edvinsson L
Br J Pharmacol; 1994 Feb; 111(2):445-54. PubMed ID: 7911715
[TBL] [Abstract][Full Text] [Related]
15. Neuroimaging of histamine H1-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine.
Tagawa M; Kano M; Okamura N; Higuchi M; Matsuda M; Mizuki Y; Arai H; Iwata R; Fujii T; Komemushi S; Ido T; Itoh M; Sasaki H; Watanabe T; Yanai K
Br J Clin Pharmacol; 2001 Nov; 52(5):501-9. PubMed ID: 11736858
[TBL] [Abstract][Full Text] [Related]
16. Effects of first and second generation antihistamines on muscarinic induced mucus gland cell ion transport.
Liu H; Farley JM
BMC Pharmacol; 2005 Mar; 5():8. PubMed ID: 15790419
[TBL] [Abstract][Full Text] [Related]
17. Can human allergy drug fexofenadine, an antagonist of histamine (H
Sader S; Cai J; Muller ACG; Wu C
J Mol Graph Model; 2017 Aug; 75():106-116. PubMed ID: 28544909
[TBL] [Abstract][Full Text] [Related]
18. Nasal allergic response mediated by histamine H3 receptors in murine allergic rhinitis.
Nakaya M; Fukushima Y; Takeuchi N; Kaga K
Laryngoscope; 2005 Oct; 115(10):1778-84. PubMed ID: 16222194
[TBL] [Abstract][Full Text] [Related]
19. Effects of fexofenadine and hydroxyzine on brake reaction time during car-driving with cellular phone use.
Tashiro M; Horikawa E; Mochizuki H; Sakurada Y; Kato M; Inokuchi T; Ridout F; Hindmarch I; Yanai K
Hum Psychopharmacol; 2005 Oct; 20(7):501-9. PubMed ID: 16086364
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography evaluation of sedative properties of antihistamines.
Yanai K; Zhang D; Tashiro M; Yoshikawa T; Naganuma F; Harada R; Nakamura T; Shibuya K; Okamura N
Expert Opin Drug Saf; 2011 Jul; 10(4):613-22. PubMed ID: 21521134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
